TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?
Authors
Keywords
-
Journal
CLINICAL SCIENCE
Volume 133, Issue 10, Pages 1145-1166
Publisher
Portland Press Ltd.
Online
2019-05-16
DOI
10.1042/cs20181116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease
- (2018) Milica Bozic et al. ATHEROSCLEROSIS
- Fas and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Are Closely Linked to the Levels of Glycated and Fetal Hemoglobin in Patients with Diabetes Mellitus
- (2018) Jong Choi et al. Clinical Laboratory
- Tumour necrosis factor-related apoptosis-inducing ligand expression in patients with diabetic nephropathy
- (2018) Wei-wei Chang et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases
- (2018) Luc Rochette et al. PHARMACOLOGY & THERAPEUTICS
- Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis
- (2018) Rupert W. Major et al. PLoS One
- TWEAK increases CD74 expression and sensitizes to DDT proinflammatory actions in tubular cells
- (2018) Lara Valiño-Rivas et al. PLoS One
- TWEAK and RIPK1 mediate a second wave of cell death during AKI
- (2018) Diego Martin-Sanchez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural principles of tumor necrosis factor superfamily signaling
- (2018) Éva S. Vanamee et al. Science Signaling
- Structural principles of tumor necrosis factor superfamily signaling
- (2018) Éva S. Vanamee et al. Science Signaling
- Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population
- (2018) Adrian Covic et al. Lancet Diabetes & Endocrinology
- Lower maternal serum tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in early preeclampsia. A retrospective study
- (2018) Danila Morano et al. Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health
- TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress
- (2018) Veronica Tisato et al. MEDIATORS OF INFLAMMATION
- Global epidemiology and outcomes of acute kidney injury
- (2018) Eric A. J. Hoste et al. Nature Reviews Nephrology
- Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease
- (2018) Maria Vittoria Arcidiacono et al. PLoS One
- An integrative systems biology approach for precision medicine in diabetic kidney disease
- (2018) Skander Mulder et al. DIABETES OBESITY & METABOLISM
- MAGE genes in the kidney: identification of MAGED2 as upregulated during kidney injury and in stressed tubular cells
- (2018) Lara Valiño-Rivas et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes Development
- (2017) Xavier Escoté et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms
- (2017) Liyu He et al. KIDNEY INTERNATIONAL
- Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
- (2017) Adeera Levin et al. LANCET
- Low Circulating TRAIL Levels Are Associated with Increase of Resistin and Lipocalin-2/ngal Adipokines in Postmenopausal Women
- (2017) Veronica Tisato et al. MEDIATORS OF INFLAMMATION
- TWEAK/Fn14 Activation Participates in Skin Inflammation
- (2017) Qilu Liu et al. MEDIATORS OF INFLAMMATION
- Phase I Study of Enavatuzumab, a First-in-Class Humanized Monoclonal Antibody Targeting the TWEAK Receptor, in Patients with Advanced Solid Tumors
- (2017) Elaine T. Lam et al. MOLECULAR CANCER THERAPEUTICS
- Roles of tumour necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible 14 pathway in lupus nephritis
- (2017) Jingyun Chen et al. NEPHROLOGY
- TWEAK/Fn14 signaling in tumors
- (2017) Guanglei Hu et al. TUMOR BIOLOGY
- Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients
- (2017) Stella Bernardi et al. BMC Nephrology
- Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells
- (2017) Shiming Ye et al. Journal of Immunology Research
- Regulation of Neuroinflammation: What Role for the Tumor Necrosis Factor-Like Weak Inducer of Apoptosis/Fn14 Pathway?
- (2017) Audrey Boulamery et al. Frontiers in Immunology
- Regulation of Fn14 Receptor and NF-κB Underlies Inflammation in Meniere’s Disease
- (2017) Lidia Frejo et al. Frontiers in Immunology
- Chronic kidney disease
- (2017) Paola Romagnani et al. Nature Reviews Disease Primers
- Osteoprotegerin and osteoprotegerin/TRAIL ratio are associated with cardiovascular dysfunction and mortality among patients with renal failure
- (2016) Marek Kuźniewski et al. Advances in Medical Sciences
- Risk of ESRD in the United States
- (2016) Patrick Albertus et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- NFκBiz protein downregulation in acute kidney injury: Modulation of inflammation and survival in tubular cells
- (2016) Jonay Poveda et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- High circulating osteoprotegerin levels are associated with non-zero blood groups
- (2016) Elod Erno Nagy et al. BMC Cardiovascular Disorders
- Population pharmacokinetic and pharmacodynamic analysis of BIIB023, an anti-TNF-like weak inducer of apoptosis (anti-TWEAK) monoclonal antibody
- (2016) Gerald R. Galluppi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Tweak up-regulates endothelin-1 system in mouse and human endothelial cells
- (2016) Patricia Martínez-Miguel et al. CARDIOVASCULAR RESEARCH
- Clinical perspectives of TRAIL: insights into central nervous system disorders
- (2016) Veronica Tisato et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD
- (2016) V. Fernandez-Laso et al. Clinical Journal of the American Society of Nephrology
- Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment
- (2016) Veronica Tisato et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis
- (2016) Megan L. Goodall et al. DEVELOPMENTAL CELL
- Renal microRNA- and RNA-profiles in progressive chronic kidney disease
- (2016) Michael Rudnicki et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Cell death-independent activities of the death receptors CD95, TRAILR1, and TRAILR2
- (2016) Daniela Siegmund et al. FEBS Journal
- Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity
- (2016) Rebecca Voltan et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mitogen-Activated Protein Kinase 14 Promotes AKI
- (2016) Alberto Ortiz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Intradialytic Cardiac Magnetic Resonance Imaging to Assess Cardiovascular Responses in a Short-Term Trial of Hemodiafiltration and Hemodialysis
- (2016) Charlotte Buchanan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The inflammatory cytokine TWEAK decreases PGC-1α expression and mitochondrial function in acute kidney injury
- (2016) Olga Ruiz-Andres et al. KIDNEY INTERNATIONAL
- Urinary osteoprotegerin: a potential biomarker of lupus nephritis disease activity
- (2016) R Gupta et al. LUPUS
- Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System
- (2016) Barbara Toffoli et al. MEDIATORS OF INFLAMMATION
- Out of the TWEAKlight: Elucidating the Role of Fn14 and TWEAK in Acute Kidney Injury
- (2016) Ana B. Sanz et al. SEMINARS IN NEPHROLOGY
- TWEAK favors phosphate-induced calcification of vascular smooth muscle cells through canonical and non-canonical activation of NFκB
- (2016) L Hénaut et al. Cell Death & Disease
- Autosomal Dominant Polycystic Disease is Associated with Depressed Levels of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand
- (2016) Funda Sari et al. Balkan Medical Journal
- Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease
- (2016) Stella Bernardi et al. Biomed Research International
- Non-canonical NFκB activation promotes chemokine expression in podocytes
- (2016) Lara Valiño-Rivas et al. Scientific Reports
- Serum TRAIL levels increase shortly after insulin therapy and metabolic stabilization in children with type 1 diabetes mellitus
- (2015) Gianluca Tornese et al. ACTA DIABETOLOGICA
- US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States
- (2015) Rajiv Saran et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Targeting TRAIL in the treatment of cancer: new developments
- (2015) Bora Lim et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction
- (2015) Shuichi Sato et al. FASEB JOURNAL
- TNF-related weak inducer of apoptosis (TWEAK) regulates junctional proteins in tubular epithelial cells via canonical NF-κB pathway and ERK activation
- (2015) Sergio Berzal et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Markers of Inflammation Associated with Plaque Progression and Instability in Patients with Carotid Atherosclerosis
- (2015) Enrico Ammirati et al. MEDIATORS OF INFLAMMATION
- Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease
- (2015) Merlin C. Thomas et al. Nature Reviews Nephrology
- The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics
- (2015) J G Perez et al. ONCOGENE
- Osteoprotegerin in Cardiometabolic Disorders
- (2015) C. Pérez de Ciriza et al. International Journal of Endocrinology
- TRAIL Modulates the Immune System and Protects against the Development of Diabetes
- (2015) Fleur Bossi et al. Journal of Immunology Research
- Regulation of Tissue Responses: The TWEAK/Fn14 Pathway and Other TNF/TNFR Superfamily Members That Activate Non-Canonical NFκB Signaling
- (2015) Linda C. Burkly Frontiers in Immunology
- Elevated Osteoprotegerin Predicts Declining Renal Function in Elderly Women: A 10-Year Prospective Cohort Study
- (2014) Joshua R. Lewis et al. AMERICAN JOURNAL OF NEPHROLOGY
- A Phase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers
- (2014) U. N. Lassen et al. CLINICAL CANCER RESEARCH
- Chronic kidney disease and cardiovascular complications
- (2014) Luca Di Lullo et al. HEART FAILURE REVIEWS
- Inverse Correlation Between Circulating Levels of TNF-Related Apoptosis-Inducing Ligand and 17β-Estradiol
- (2014) Giorgio Zauli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Osteoprotegerin and kidney disease
- (2014) Alejandra Montañez-Barragán et al. JOURNAL OF NEPHROLOGY
- Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes
- (2014) Stella Bernardi et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- TWEAK and the progression of renal disease: clinical translation
- (2014) A. B. Sanz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- TRAIL Deficiency Contributes to Diabetic Nephropathy in Fat-Fed ApoE-/- Mice
- (2014) Siân P. Cartland et al. PLoS One
- Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model
- (2014) Veronica Tisato et al. PLoS One
- TWEAK/Fn14 axis: The current paradigm of tissue injury-inducible function in the midst of complexities
- (2014) Linda C. Burkly SEMINARS IN IMMUNOLOGY
- The levels of circulating TRAIL at the onset of type 1 diabetes are markedly decreased in patients with ketoacidosis and with the highest insulin requirement
- (2013) Gianluca Tornese et al. ACTA DIABETOLOGICA
- Blockade of Death Ligand TRAIL Inhibits Renal Ischemia Reperfusion Injury
- (2013) Takaomi Adachi et al. ACTA HISTOCHEMICA ET CYTOCHEMICA
- TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast
- (2013) Alvaro C. Ucero et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Fn14 in podocytes and proteinuric kidney disease
- (2013) Maria Dolores Sanchez-Niño et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Circulating level of TRAIL concentration is positively associated with endothelial function and increased by diabetic therapy in the newly diagnosed type 2 diabetic patients
- (2013) Guangda Xiang et al. CLINICAL ENDOCRINOLOGY
- World Incidence of AKI: A Meta-Analysis
- (2013) P. Susantitaphong et al. Clinical Journal of the American Society of Nephrology
- The osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the kidney
- (2013) Riccardo Candido CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes
- (2013) D. Gordin et al. DIABETES CARE
- Serum sTWEAK Concentrations and Risk of Developing Type 2 Diabetes in a High Cardiovascular Risk Population: A Nested Case-Control Study
- (2013) Andrés Díaz-López et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease
- (2013) Jose M. Valdivielso et al. JOURNAL OF NEPHROLOGY
- TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammation
- (2013) Sandra Rayego-Mateos et al. JOURNAL OF PATHOLOGY
- Clinical targeting of the TNF and TNFR superfamilies
- (2013) Michael Croft et al. NATURE REVIEWS DRUG DISCOVERY
- p-Cresyl sulphate has pro-inflammatory and cytotoxic actions on human proximal tubular epithelial cells
- (2013) Jonay Poveda et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A Polymeric Nanomedicine Diminishes Inflammatory Events in Renal Tubular Cells
- (2013) Álvaro C. Ucero et al. PLoS One
- Osteoprotegerin in Exosome-Like Vesicles from Human Cultured Tubular Cells and Urine
- (2013) Alberto Benito-Martin et al. PLoS One
- Association of circulating sTRAIL and high-sensitivity CRP with type 2 diabetic nephropathy and foot ulcers
- (2013) Ahter Dilsad Sanlioglu MEDICAL SCIENCE MONITOR
- TWEAK: A New Player in Obesity and Diabetes
- (2013) Joan Vendrell et al. Frontiers in Immunology
- Attenuation of TNFSF10/TRAIL-induced apoptosis by an autophagic survival pathway involving TRAF2- and RIPK1/RIP1-mediated MAPK8/JNK activation
- (2012) Weiyang He et al. Autophagy
- TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
- (2012) S Jouan-Lanhouet et al. CELL DEATH AND DIFFERENTIATION
- Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria
- (2012) Shen-tian Wang et al. CLINICAL NEPHROLOGY
- The energy balance positively regulates the levels of circulating TNF-related apoptosis inducing ligand in humans
- (2012) Gianni Biolo et al. CLINICAL NUTRITION
- TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation
- (2012) Stella Bernardi et al. CLINICAL SCIENCE
- Potential Role of TRAIL in the Management of Autoimmune Diabetes Mellitus
- (2012) Stella Bernardi et al. CURRENT PHARMACEUTICAL DESIGN
- Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients
- (2012) A. Bisgin et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Soluble TRAIL is elevated in recurrent miscarriage and inhibits the in vitro adhesion and migration of HTR8 trophoblastic cells
- (2012) C. Agostinis et al. HUMAN REPRODUCTION
- Role of TWEAK in lupus nephritis: A bench-to-bedside review
- (2012) Jennifer S. Michaelson et al. JOURNAL OF AUTOIMMUNITY
- TRAIL death receptor 4 signaling via lysosome fusion and membrane raft clustering in coronary arterial endothelial cells: evidence from ASM knockout mice
- (2012) Xiang Li et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- TWEAK (tumor necrosis factor–like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation
- (2012) María Concepción Izquierdo et al. KIDNEY INTERNATIONAL
- Serum Levels of TWEAK and Scavenger Receptor CD163 in Type 1 Diabetes Mellitus: Relationship with Cardiovascular Risk Factors. A Case-Control Study
- (2012) Gemma Llauradó et al. PLoS One
- State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL
- (2012) Stella Bernardi et al. Recent Patents on Anti-Cancer Drug Discovery
- Serum Receptor Activator of Nuclear Factor-κ B Ligand, Osteoprotegrin, and Intact Parathyroid Hormone in Hemodialysis and Renal Transplant Patients
- (2012) Nadereh Rashtchizadeh et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop
- (2011) Barbara Toffoli et al. ATHEROSCLEROSIS
- Endogenous Testosterone, Endothelial Dysfunction, and Cardiovascular Events in Men with Nondialysis Chronic Kidney Disease
- (2011) M. I. Yilmaz et al. Clinical Journal of the American Society of Nephrology
- Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus
- (2011) Chao Wang et al. CLINICAL RHEUMATOLOGY
- TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice
- (2011) B. A. Di Bartolo et al. DIABETOLOGIA
- Correlations of Urinary Biomarkers, TNF-Like Weak Inducer of Apoptosis (TWEAK), Osteoprotegerin (OPG), Monocyte Chemoattractant Protein-1 (MCP-1), and IL-8 with Lupus Nephritis
- (2011) Amal El-shehaby et al. JOURNAL OF CLINICAL IMMUNOLOGY
- The Inflammatory Cytokines TWEAK and TNF Reduce Renal Klotho Expression through NF B
- (2011) J. A. Moreno et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study
- (2011) A. VIK et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- TWEAK, a multifunctional cytokine in kidney injury
- (2011) Ana Belen Sanz et al. KIDNEY INTERNATIONAL
- Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy
- (2011) Yu-Hung Chang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Metalloproteinase 2 cleaves in vitro recombinant TRAIL: Potential implications for the decreased serum levels of TRAIL after acute myocardial infarction
- (2010) Paola Secchiero et al. ATHEROSCLEROSIS
- Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults
- (2010) Stefano Volpato et al. ATHEROSCLEROSIS
- Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms
- (2010) P. A. Culp et al. CLINICAL CANCER RESEARCH
- Urinary Biomarkers in Lupus Nephritis
- (2010) Joyce Reyes-Thomas et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Treatment With Recombinant Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Alleviates the Severity of Streptozotocin-Induced Diabetes
- (2010) G. Zauli et al. DIABETES
- Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity
- (2010) Shreenidhi M. Venuraju et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease
- (2010) S. JONO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Diabetic kidney disease: act now or pay later
- (2010) Robert C. Atkins et al. KIDNEY INTERNATIONAL
- Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury
- (2010) Kiyohiko Hotta et al. KIDNEY INTERNATIONAL
- Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets
- (2010) Barbara Toffoli et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Inflammation, kidney function and albuminuria in the Framingham Offspring cohort
- (2010) Ashish Upadhyay et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients
- (2010) S. Liabeuf et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21
- (2010) Ana B. Sanz et al. PLoS One
- Review: Interplay of Iron Metallobiology, Metalloproteinases, and FXIII, and Role of Their Gene Variants in Venous Leg Ulcer
- (2010) Ajay V Singh et al. International Journal of Lower Extremity Wounds
- Tumor Necrosis Factor–Like Weak Inducer of Apoptosis (TWEAK) Enhances Vascular and Renal Damage Induced by Hyperlipidemic Diet in ApoE-Knockout Mice
- (2009) Begoña Muñoz-García et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects
- (2009) Vinh Nguyen et al. CLINICAL IMMUNOLOGY
- Soluble TWEAK Plasma Levels as a Novel Biomarker of Endothelial Function in Patients with Chronic Kidney Disease
- (2009) M. I. Yilmaz et al. Clinical Journal of the American Society of Nephrology
- TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells
- (2009) Hua-Xin Gao et al. CYTOKINE
- Prognostic value of apoptosis markers in advanced heart failure patients
- (2009) A. Niessner et al. EUROPEAN HEART JOURNAL
- Adenovirus-Mediated TRAIL Gene (Ad5hTRAIL) Delivery into Pancreatic Islets Prolongs Normoglycemia in Streptozotocin-Induced Diabetic Rats
- (2009) Ercument Dirice et al. HUMAN GENE THERAPY
- Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis
- (2009) Dinanda J. de Jager JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia
- (2009) Ana B. Sanz et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Urine Osteoprotegerin and Monocyte Chemoattractant Protein-1 in Lupus Nephritis
- (2009) A. N. KIANI et al. JOURNAL OF RHEUMATOLOGY
- Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction
- (2009) Paola Secchiero et al. PLoS One
- Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study
- (2009) Noa Schwartz et al. ARTHRITIS RESEARCH & THERAPY
- TRAIL receptor signalling and modulation: Are we on the right TRAIL?
- (2008) Devalingam Mahalingam et al. CANCER TREATMENT REVIEWS
- Additive Effects of Soluble TWEAK and Inflammation on Mortality in Hemodialysis Patients
- (2008) J. J. Carrero et al. Clinical Journal of the American Society of Nephrology
- To kill a tumor cell: the potential of proapoptotic receptor agonists
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanisms of Renal Apoptosis in Health and Disease
- (2008) A. B. Sanz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Cytokine TWEAK Modulates Renal Tubulointerstitial Inflammation
- (2008) A. B. Sanz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Death Ligand TRAIL in Diabetic Nephropathy
- (2008) C. Lorz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease
- (2007) Susan Kralisch et al. ATHEROSCLEROSIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started